Erasca Shares Plunge 48% After Trial Patient Death, Patent Dispute Emerges [Yahoo! Finance]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Yahoo! Finance
cancer-drug developer disclosed a patient death linked to severe side effects in its clinical trial, a development that could complicate the company's broader safety narrative. The patient, a 66-year-old man, reportedly developed severe lung inflammation about a month after starting the therapy, later discontinuing treatment and subsequently dying. The update arrived alongside early-stage data that the company said showed its treatment was generally well-tolerated, with mostly low-grade side events, creating a sharp contrast that could raise questions among investors about how these outcomes should be interpreted. Warning! GuruFocus has detected 4 Warning Sign with RVMD. Is RVMD fairly valued? Test your thesis with our free DCF calculator. The selloff marks the largest drop in the company's share price since its 2021 public listing and adds to pressure following a separate setback a day earlier. On Monday, Revolution Medicines Inc. ( NASDAQ:RVMD ) issued a cease-and-desist lette
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026GlobeNewswire
- Revolution's on a pancreatic cancer winning streak. What comes next for the biotech? [Yahoo! Finance]Yahoo! Finance
- Assessing Revolution Medicines (RVMD) Valuation After Positive RASolute 302 And Zoldonrasib Clinical Updates [Yahoo! Finance]Yahoo! Finance
- Erasca shares sink after patient death in early-stage cancer drug trial [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug [FOX News]FOX News
RVMD
Earnings
- 2/25/26 - Miss
RVMD
Sec Filings
- 4/29/26 - Form 4
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form ARS
- RVMD's page on the SEC website